Annette North

Business address
C/O Sgx Pharmaceuticals, Inc., 10505 Roselle Street, San Diego, CA, 92121
Top holdings (ownership)
TPTX
Get insider transactions for this reporting owner
Annette North has filed 24 SEC EDGAR filings since 31 Jan 2006

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 SUBMISSION 11 Feb 2022 09 Feb 2022 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION 31 Aug 2021 30 Aug 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION 16 Jun 2021 15 Jun 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION 07 May 2021 06 May 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION 09 Mar 2021 08 Mar 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION 10 Feb 2021 08 Feb 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION 02 Feb 2021 01 Feb 2021 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION 08 Jan 2020 06 Jan 2020 001-38871
3 Open Document Open Filing FORM 3 SUBMISSION 16 Apr 2019 16 Apr 2019 001-38871
4 Open Document Open Filing FORM 4 SUBMISSION 24 Jan 2019 22 Jan 2019 001-37620
4 Open Document Open Filing FORM 4 SUBMISSION 26 Jan 2018 24 Jan 2018 001-37620
4 Open Document Open Filing FORM 4 SUBMISSION 25 Jan 2017 23 Jan 2017 001-37620
4 Open Document Open Filing FORM 4 SUBMISSION 02 Feb 2016 29 Jan 2016 001-37620
4 Open Document Open Filing FORM 4 SUBMISSION 27 Apr 2015 23 Apr 2015 000-53058
3 Open Document Open Filing FORM 3 SUBMISSION 16 Mar 2015 06 Mar 2015 000-53058
4 Open Document Open Filing PRIMARY DOCUMENT 12 Nov 2014 10 Nov 2014 001-35919
4 Open Document Open Filing 4 19 May 2014 15 May 2014 001-35919
4 Open Document Open Filing FORM 4 10 Jan 2014 08 Jan 2014 001-35919